These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26890818)

  • 21. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased protein S activity is related to the disease activity of Behcet's disease.
    Kwon SR; Lim MJ; Park SG; Moon YS; Park W
    Rheumatol Int; 2006 Nov; 27(1):39-43. PubMed ID: 16969634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The performance of different classification criteria in paediatric Behçet's disease.
    Batu ED; Sönmez HE; Sözeri B; Butbul Aviel Y; Bilginer Y; Özen S
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):119-123. PubMed ID: 28406761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a relation between clinical disease activity and acute phase response in Behcet's disease?
    Melikoglu M; Topkarci Z
    Int J Dermatol; 2014 Feb; 53(2):250-4. PubMed ID: 24261602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-cardiolipin and anti-Neutrophil Cytoplasmic Antibodies in Iranian patients with Behcet's disease.
    Ataollahi MR; Aflaki E; Nazarinia MA; Shenavandeh S; Habibagahi Z; Gharesi-Fard B; Kamali-Sarvestani E
    Iran J Immunol; 2012 Dec; 9(4):241-7. PubMed ID: 23268290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
    Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
    Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.
    Neves FS; Carrasco S; Goldenstein-Schainberg C; Gonçalves CR; de Mello SB
    Clin Rheumatol; 2009 Dec; 28(12):1403-10. PubMed ID: 19701803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased sucrose permeability in Behçet's disease.
    Koc B; Aymelek S; Sonmez A; Yilmaz MI; Kocar H
    Rheumatol Int; 2004 Nov; 24(6):347-50. PubMed ID: 14530866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
    Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase I and II autoantibodies in Behçet's disease.
    Mentese A; Alver A; Demir S; Sumer A; Ozer Yaman S; Karkucak M; Aydin Capkin A; Us Altay D; Turan I
    Acta Reumatol Port; 2017; 42(1):26-31. PubMed ID: 28198796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical Practice.
    Kim B; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Gut Liver; 2015 Nov; 9(6):750-5. PubMed ID: 25963076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-driven assessment of disease activity in Behçet's syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet's Syndrome Activity Score.
    Yilmaz S; Simsek I; Cinar M; Erdem H; Kose O; Yazici Y; Pay S
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):77-83. PubMed ID: 24064020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between red blood cell distribution width and disease activity in patients with Behçet's disease.
    Aksoy ŞN; Savaş E; Sucu M; Kisacik B; Kul S; Zengin O
    J Int Med Res; 2015 Dec; 43(6):765-73. PubMed ID: 26359293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
    Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
    Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
    Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors for anemia among newly-diagnosed intestinal Behcet's disease patients.
    Ye JF; Chen Y; Cai JF; Shen Y; Zou J; Guan JL
    J Natl Med Assoc; 2019 Aug; 111(4):407-412. PubMed ID: 30803717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.